Brief: Ani Pharmaceuticals Announces The Launch Of Kionex® Suspension
20/05/2024 11:53
ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS ANNOUNCES THE LAUNCH OF KIONEX®
SUSPENSION
* ANI PHARMACEUTICALS INC: LAUNCH OF KIONEX (SODIUM
POLYSTYRENE
SULFONATE SUSPENSION USP) FOR ORAL OR RECTAL USE
Source text for Eikon: ID:nGNX1Qhn5j
Further company coverage: ANIP.O
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary